Haleon sees higher sales in 2024 as FY profits come in flat
29th Feb 2024 07:23
(Sharecast News) - Consumer health firm Haleon on Thursday posted flat annual earnings and said it expected to grow revenue this year on higher demand.
Read moreHaleon offloads ChapStick brand for $430m
25th Jan 2024 07:14
(Sharecast News) - Consumer health group Haleon, the company behind Sensodyne toothpaste, Panadol and Advil painkillers, has announced it is selling the ChapStick lip balm brand for $430m.
Read moreLondon close: Stocks rise on positive news from China
24th Jan 2024 16:31
(Sharecast News) - London markets finished with a positive performance on Wednesday, driven by gains in the mining sector following China's announcement of an upcoming reduction in the reserve requirement ratio for banks.
Read moreBroker tips: Greggs, Haleon
24th Jan 2024 15:58
(Sharecast News) - Numis initiated coverage of Greggs on Wednesday with a 'hold' rating and 2,560p price target as it said growth was "baked in".
Read moreJPMorgan puts Haleon on negative catalyst watch
24th Jan 2024 12:32
(Sharecast News) - JPMorgan has placed consumer health company Haleon on negative catalyst watch ahead of its annual report next month, saying volume and earnings risks will weigh on the stock's rating.
Read moreGSK raises £978m through Haleon share sale
17th Jan 2024 08:05
(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.
Read moreBofA Merrill Lynch reinstates Haleon at 'buy'
7th Nov 2023 13:58
(Sharecast News) - Bank of America Merrill Lynch reinstated coverage of GSK spinoff Haleon on Tuesday, with a 'buy' rating and 390p price target.
Read moreLondon close: Stocks rise as BoE keeps rates steady
2nd Nov 2023 15:12
(Sharecast News) - London's stock markets ended the day on a positive note on Thursday, following the Bank of England's decision to maintain interest rates as markets widely expected.
Read moreHaleon reiterates full-year outlook
2nd Nov 2023 07:32
(Sharecast News) - Haleon reaffirmed its full-year targets on Thursday, despite third-quarter revenues narrowly missing forecasts.
Read moreGSK raises £885.6m from Haleon share sale
6th Oct 2023 08:17
(Sharecast News) - GSK said on Friday that it has sold 270m shares in Haleon - the consumer health business it spun off last year - raising around £885.6m.
Read moreHaleon confident on outlook, raises guidance
2nd Aug 2023 07:06
(Sharecast News) - Haleon sounded a confident note on the outlook after delivering a big rise in revenues and free cash flow.
Read moreFutura Medical shares rise on ED licensing deal with Haleon
17th Jul 2023 08:33
(Sharecast News) - Shares in Futura Medical gained on Monday after the company said it signed a licensing deal with consumer heath care giant Haleon for the rights to exclusively commercialise its topical, gel-based erectile dysfunction treatment MED3000 in the USA.
Read moreGSK spinoff Haleon planning widespread layoffs - report
13th Jul 2023 15:36
(Sharecast News) - GSK spinoff Haleon is reportedly planning widespread layoffs in the UK and around the world.
Read moreGSK sells 2.4% of Haleon stake via placing for £804m
12th May 2023 07:52
(Sharecast News) - UK pharmaceuticals company GSK said it had sold a 2.5% stake in Haleon at 335p a share, raising £804m.
Read moreHaleon profits rise but margins squeezed by cost inflation
3rd May 2023 07:18
(Sharecast News) - Profits at consumer health company Haleon on Wednesday came in below expectations as higher costs hit earnings margins.
Read more